---
figid: PMC3460047__12307_2012_107_Fig5_HTML
figlink: /pmc/articles/PMC3460047/figure/Fig5/
number: Fig. 5
caption: Usually growth factors bind and activate EGFR on the cell membrane of cancer
  cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway. Gene transcriptions
  and cell viability are enhanced. However the lymphocytes and antibodies elicited
  by EGFR-based vaccine block the binding of growth factor and EGFR
pmcid: PMC3460047
papertitle: Cancer Microenvironment and Cancer Vaccine.
reftext: Zhen-Yu Ding, et al. Cancer Microenviron. 2012 Dec;5(3):333-344.
pmc_ranked_result_index: '50376'
pathway_score: 0.9490983
filename: 12307_2012_107_Fig5_HTML.jpg
figtitle: Usually growth factors bind and activate EGFR on the cell membrane of cancer
  cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway
year: '2012'
organisms: Homo sapiens
ndex: 40164cbc-dea3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3460047__12307_2012_107_Fig5_HTML.html
  '@type': Dataset
  description: Usually growth factors bind and activate EGFR on the cell membrane
    of cancer cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway.
    Gene transcriptions and cell viability are enhanced. However the lymphocytes and
    antibodies elicited by EGFR-based vaccine block the binding of growth factor and
    EGFR
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - PIK3R4
  - MAP2K2
  - MTOR
  - RAF1
  - PIK3R5
  - PIK3R6
  - NRAS
  - ARAF
  - PIK3R3
  - BRAF
  - EGFR
  - HRAS
  - PIK3CD
  - AKT1
  - PIK3CB
  - KRAS
  - AKT3
  - AKT2
  - PIK3CG
  - PIK3CA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
